MMP9 and breast carcinoma: Wang et al. verified that miR-204-5p directly targeted MMP9 competitive binding through diluciferase reporter enzyme experiment in atherosclerosis-associated abnormal human vascular smooth muscle cells (hVSMC) and MCF-7 breast cancer cells41,42.